Startup profile · funding coverage
Infinite Athlete
Sports data OS merging Tempus Ex and Biocore — fusion feeds for NFL, Chelsea FC, Pac-12.
Stage
acquired
Status
acquired
Coverage
full
Why Infinite Athlete is interesting
Charlie Ebersol-founded; consolidated live data + biomechanics before EXOS acquisition.
Key facts
- Tempus Ex seed (2021): a16z and General Catalyst among backers before Biocore merger — Hollywood Reporter
- Rebranded Infinite Athlete (2023); served NFL, Chelsea FC, Pac-12 with fusion data feeds
- Exit (2025): Acquired by EXOS
Investors in our directory
Funds linked from Infinite Athlete's profile — open a fund page for stage focus and related deal articles.
Industries
Media & Entertainment
Industry hub pages are rolling out from our fund-derived baseline taxonomy.
Related funding articles
Venture Capital Tracker pieces that cover Infinite Athlete's financing or category context.
FAQs about Infinite Athlete
Funding context and why this company shows up in venture coverage.
Infinite Athlete merged live sports data (Tempus Ex) and biomechanics (Biocore) into fusion feeds for leagues and broadcasters.
Andreessen Horowitz (see /fund/andreessen-horowitz) and General Catalyst (/fund/general-catalyst) backed the Tempus Ex entity before the merger.
Tempus Ex raised seed funding in 2021; post-merger round details are limited in public sources.
It combined real-time game data with player biomechanics — a unified sports data layer for leagues and media partners.
EXOS acquired Infinite Athlete in 2025.
Last updated: 2026-07-24